Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study

The Lancet

Volumn 389, Issue 10087, 2017, Pages 2383-2392

  Chakravarty, Tarun ^a   Søndergaard, Lars ^b   Friedman, John ^a   De Backer, Ole ^b   Berman, Daniel ^a   Kofoed, Klaus F ^b   Jilaihawi, Hasan ^c   Shiota, Takahiro ^a   Abramowitz, Yigal ^a   Jørgensen, Troels H ^b   Rami, Tanya ^a   Israr, Sharjeel ^a   Fontana, Gregory ^d   de Knegt, Martina ^b   Fuchs, Andreas ^b   Lyden, Patrick ^a   Trento, Alfredo ^a   Bhatt, Deepak L ^e   Leon, Martin B ^f   Makkar, Raj R ^a   Ramzy, Danny ^g   Cheng, Wen ^g   Siegel, Robert J ^g   Thomson, Louise M ^g   Mangat, Geeteshwar ^g   Hariri, Babak ^g   Sawaya, Fadi J ^g   Iversen, Helle K ^g   more..

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Rigshospitalet   (Denmark)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d Los Robles Regional Medical Center   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NewYork Presbyterian Hospital   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC IMAGING; CLINICAL OUTCOME; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; DUAL ANTIPLATELET THERAPY; FEMALE; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HEART HEMODYNAMICS; HEART MOVEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POSTOPERATIVE THROMBOSIS; PREVALENCE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; REGISTER; SUBCLINICAL LEAFLET THROMBOSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; ADVERSE DEVICE EFFECT; AORTIC VALVE; BIOPROSTHESIS; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HEART VALVE PROSTHESIS; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS COMPLICATION; PROSTHESIS DESIGN; SURGERY; THROMBOSIS; VALVULAR HEART DISEASE; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; AORTIC VALVE; BIOPROSTHESIS; ECHOCARDIOGRAPHY; FEMALE; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MALE; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REGISTRIES; THROMBOSIS; TOMOGRAPHY, X-RAY COMPUTED; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85015652413     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)30757-2     Document Type: Article

References (26)

1. Mack, MJ, Leon, MB, Smith, CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2477–2484.
2. Leon, MB, Smith, CR, Mack, MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374 (2016), 1609–1620.
3. Thourani, VH, Kodali, S, Makkar, RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387 (2016), 2218–2225.
4. Popma, JJ, Adams, DH, Reardon, MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63 (2014), 1972–1981.
5. Adams, DH, Popma, JJ, Reardon, MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370 (2014), 1790–1798.
6. Kapadia, SR, Leon, MB, Makkar, RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2485–2491.
7. Søndergaard, L, Steinbruchel, DA, Ihlemann, N, et al. Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers Nordic Aortic Valve Intervention randomized clinical trial. Circ Cardiovasc Interv, 9, 2016, 6.
8. Makkar, RR, Fontana, G, Jilaihawi, H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373 (2015), 2015–2024.
9. Hansson, NC, Grove, EL, Andersen, HR, et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol 68 (2016), 2059–2069.
10. Pache, G, Schoechlin, S, Blanke, P, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J 37 (2016), 2263–2271.
11. Yanagisawa, R, Hayashida, K, Yamada, Y, et al. Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR. JACC Cardiovasc Imaging, 2016, 10.1016/j.jcmg.2016.11.005 published online Dec 8.
12. Ruile, P, Jander, N, Blanke, P, et al. Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation. Clin Res Cardiol 106 (2017), 85–95.
13. Leetmaa, T, Hansson, NC, Leipsic, J, et al. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv, 8, 2015, 4.
14. Kappetein, AP, Head, SJ, Généreux, P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60 (2012), 1438–1454.
15. Amahzoune, B, Bruneval, P, Allam, B, Lafont, A, Fabiani, JN, Zegdi, R, Traumatic leaflet injury during the use of percutaneous valves: a comparative study of balloon- and self-expandable valved stents. Eur J Cardiothorac Surg 43 (2013), 488–493.
16. Alavi, SH, Groves, EM, Kheradvar, A, The effects of transcatheter valve crimping on pericardial leaflets. Ann Thorac Surg 97 (2014), 1260–1266.
17. de Buhr, W, Pfeifer, S, Slotta-Huspenina, J, Wintermantel, E, Lutter, G, Goetz, WA, Impairment of pericardial leaflet structure from balloon-expanded valved stents. J Thorac Cardiovasc Surg 143 (2012), 1417–1421.
18. Martin, C, Sun, W, Comparison of transcatheter aortic valve and surgical bioprosthetic valve durability: a fatigue simulation study. J Biomech 48 (2015), 3026–3034.
19. Reardon, MJ, Kleiman, NS, Adams, DH, et al. Outcomes in the randomized CoreValve US Pivotal High Risk Trial in patients with a society of thoracic surgeons risk score of 7% or less. JAMA cardiol 1 (2016), 945–949.
20. Leon, MB, Smith, CR, Mack, M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
21. Smith, CR, Leon, MB, Mack, MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364 (2011), 2187–2198.
22. Mangione, FM, Jatene, T, Goncalves, A, et al. Leaflet thrombosis in surgically explanted or post-mortem TAVR valves. JACC Cardiovasc Imaging 10 (2017), 82–85.
23. Nishimura, RA, Otto, CM, Bonow, RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), e57–185.
24. Vahanian, A, Alfieri, O, Andreotti, F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33 (2012), 2451–2496.
25. Genereux, P, Cohen, DJ, Williams, MR, et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63 (2014), 1100–1109.
26. Genereux, P, Cohen, DJ, Mack, M, et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol 64 (2014), 2605–2615.